Article Details
Retrieved on: 2020-12-04 07:59:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vanguard Group Inc. now owns 4,637,637 shares of the biopharmaceutical company's stock valued at $386,547,000 after purchasing an additional ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here